N/A
Manufactured by MONAT GLOBAL CORP
9,433 FDA adverse event reports analyzed
Last updated: 2026-04-15
ZINC OXIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by MONAT GLOBAL CORP. The most commonly reported adverse reactions for ZINC OXIDE include DRUG INEFFECTIVE, MACULAR DEGENERATION, PYREXIA, OFF LABEL USE, PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ZINC OXIDE.
Out of 1,946 classified reports for ZINC OXIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 9,433 FDA FAERS reports that mention ZINC OXIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, MACULAR DEGENERATION, PYREXIA, OFF LABEL USE, PAIN, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list MONAT GLOBAL CORP in connection with ZINC OXIDE. Always verify the specific product and NDC with your pharmacist.